$AKYA
Akoya Biosciences, Inc.

2022 Q1 Form 10-Q Financial Statement

#000155837022007462 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $16.89M $12.21M
YoY Change 38.34% 10.82%
Cost Of Revenue $6.798M $4.807M
YoY Change 41.42% 11.02%
Gross Profit $10.10M $7.405M
YoY Change 36.34% 10.52%
Gross Profit Margin 59.76% 60.64%
Selling, General & Admin $18.19M $8.179M
YoY Change 122.44% 28.8%
% of Gross Profit 180.2% 110.45%
Research & Development $5.714M $3.192M
YoY Change 79.01% 34.68%
% of Gross Profit 56.6% 43.11%
Depreciation & Amortization $1.619M $1.041M
YoY Change 55.52% 15.67%
% of Gross Profit 16.04% 14.06%
Operating Expenses $25.65M $12.81M
YoY Change 100.3% 59.08%
Operating Profit -$15.55M -$5.401M
YoY Change 187.98% 300.07%
Interest Expense -$749.0K -$751.0K
YoY Change -0.27% 17.34%
% of Operating Profit
Other Income/Expense, Net -$74.00K -$66.00K
YoY Change 12.12% -40.0%
Pretax Income -$16.38M -$8.088M
YoY Change 102.49% 283.32%
Income Tax $22.00K -$6.000K
% Of Pretax Income
Net Earnings -$16.40M -$8.082M
YoY Change 102.91% 277.13%
Net Earnings / Revenue -97.07% -66.18%
Basic Earnings Per Share -$0.44 -$3.54
Diluted Earnings Per Share -$0.44 -$3.54
COMMON SHARES
Basic Shares Outstanding 37.46M 2.706M
Diluted Shares Outstanding 37.46M 2.706M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.94M $11.69M
YoY Change 703.58%
Cash & Equivalents $93.94M $12.19M
Short-Term Investments
Other Short-Term Assets $9.841M $1.040M
YoY Change 846.25%
Inventory $11.37M $4.720M
Prepaid Expenses
Receivables $11.31M $6.590M
Other Receivables $0.00 $0.00
Total Short-Term Assets $126.5M $24.03M
YoY Change 426.28%
LONG-TERM ASSETS
Property, Plant & Equipment $7.588M $7.880M
YoY Change -3.71%
Goodwill $18.26M
YoY Change
Intangibles $20.96M
YoY Change
Long-Term Investments
YoY Change
Other Assets $341.0K $2.140M
YoY Change -84.07%
Total Long-Term Assets $60.66M $50.45M
YoY Change 20.24%
TOTAL ASSETS
Total Short-Term Assets $126.5M $24.03M
Total Long-Term Assets $60.66M $50.45M
Total Assets $187.1M $74.48M
YoY Change 151.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.52M $5.780M
YoY Change 99.27%
Accrued Expenses $12.14M $6.410M
YoY Change 89.36%
Deferred Revenue $4.892M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $383.0K $1.520M
YoY Change -74.8%
Total Short-Term Liabilities $31.74M $20.56M
YoY Change 54.36%
LONG-TERM LIABILITIES
Long-Term Debt $32.58M $33.79M
YoY Change -3.59%
Other Long-Term Liabilities $15.78M $9.680M
YoY Change 63.02%
Total Long-Term Liabilities $32.58M $43.47M
YoY Change -25.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.74M $20.56M
Total Long-Term Liabilities $32.58M $43.47M
Total Liabilities $80.58M $64.18M
YoY Change 25.55%
SHAREHOLDERS EQUITY
Retained Earnings -$112.5M
YoY Change
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $106.6M -$60.00M
YoY Change
Total Liabilities & Shareholders Equity $187.1M $74.48M
YoY Change 151.25%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$16.40M -$8.082M
YoY Change 102.91% 277.13%
Depreciation, Depletion And Amortization $1.619M $1.041M
YoY Change 55.52% 15.67%
Cash From Operating Activities -$17.93M -$4.404M
YoY Change 307.18% 358.75%
INVESTING ACTIVITIES
Capital Expenditures $1.138M $907.0K
YoY Change 25.47% -35.21%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.138M -$907.0K
YoY Change 25.47% -37.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -71.00K -4.000K
YoY Change 1675.0% -99.85%
NET CHANGE
Cash From Operating Activities -17.93M -4.404M
Cash From Investing Activities -1.138M -907.0K
Cash From Financing Activities -71.00K -4.000K
Net Change In Cash -19.14M -5.315M
YoY Change 260.13% 5.04%
FREE CASH FLOW
Cash From Operating Activities -$17.93M -$4.404M
Capital Expenditures $1.138M $907.0K
Free Cash Flow -$19.07M -$5.311M
YoY Change 259.07% 125.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37464496
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2706133
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37464496
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2706133
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001711933
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37502358
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37424101
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.54
CY2022Q1 akya Standard Service Based Warranty Terms
StandardServiceBasedWarrantyTerms
P1Y
CY2022Q1 akya Extended Service Based Warranty Terms
ExtendedServiceBasedWarrantyTerms
P1Y
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37502358
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37424101
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.54
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40344
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Akoya Biosciences, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5586242
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Campus Drive
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752
CY2022Q1 dei City Area Code
CityAreaCode
855
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
896-8401
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
AKYA
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37589555
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93938000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113079000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11314000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9444000
CY2022Q1 us-gaap Inventory Net
InventoryNet
11373000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9014000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9841000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9277000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
126466000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
140814000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7588000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7487000
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000
CY2022Q1 akya Demo Inventory Net
DemoInventoryNet
2225000
CY2021Q4 akya Demo Inventory Net
DemoInventoryNet
2548000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20960000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21150000
CY2022Q1 us-gaap Goodwill
Goodwill
18262000
CY2021Q4 us-gaap Goodwill
Goodwill
18262000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9937000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1047000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
341000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
344000
CY2022Q1 us-gaap Assets
Assets
187128000
CY2021Q4 us-gaap Assets
Assets
190907000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11518000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9435000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12138000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13491000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2805000
CY2022Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
383000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
272000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4892000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4484000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
31736000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27682000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1519000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1330000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32576000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32471000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
36000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26000
CY2021Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
197000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7506000
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
448000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
6755000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7850000
CY2022Q1 us-gaap Liabilities
Liabilities
80576000
CY2021Q4 us-gaap Liabilities
Liabilities
69556000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37502358
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37424101
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219056000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217456000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-112506000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96107000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
106552000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187128000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
190907000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16894000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12212000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
6798000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
4807000
CY2022Q1 us-gaap Gross Profit
GrossProfit
10096000
CY2021Q1 us-gaap Gross Profit
GrossProfit
7405000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18193000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8179000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5714000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3192000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
200000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
426000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1543000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1009000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
25650000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
12806000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15554000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5401000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-749000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-751000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1870000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-74000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-66000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16377000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8088000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-16399000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8082000
CY2021Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1190000
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16399000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9568000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.54
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37464496
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2706133
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-16399000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1545000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
106552000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-51026000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1190000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8082000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-60000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-16399000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8082000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1619000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1041000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
105000
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
106000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1545000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
254000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
200000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
426000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1870000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1870000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
120000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11087000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1256000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2286000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
430000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2083000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
702000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7551000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
772000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
597000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
323000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17932000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4404000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1138000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
907000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1138000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-907000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
55000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000
CY2021Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
48000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
126000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19141000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5315000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113381000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17508000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94240000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12193000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
638000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
638000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
887000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
884000
CY2021Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
1190000
CY2021Q4 akya Demo Inventory Gross
DemoInventoryGross
3733000
CY2022Q1 akya Number Of Geographic Regions For Sales
NumberOfGeographicRegionsForSales
3
CY2022Q1 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
1508000
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2.33
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93938000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-112506000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17932000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16894000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12212000
CY2022Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
44000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20960000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28022000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6872000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21150000
CY2022Q1 akya Demo Inventory Net
DemoInventoryNet
2225000
CY2021Q4 akya Demo Inventory Net
DemoInventoryNet
2548000
CY2022Q1 akya Depreciation Demo Inventory
DepreciationDemoInventory
352000
CY2021Q1 akya Depreciation Demo Inventory
DepreciationDemoInventory
103000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28450000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7490000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1924000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2511000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11844000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11555000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4256000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4068000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7588000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7487000
CY2022Q1 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2021 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2022Q1 akya Demo Inventory Gross
DemoInventoryGross
3733000
CY2021Q4 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
1185000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2630000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2630000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4240000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2601000
CY2022Q1 akya Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
8664000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20960000
CY2022Q1 us-gaap Goodwill
Goodwill
18262000
CY2021Q4 us-gaap Goodwill
Goodwill
18262000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3528000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6502000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2502000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1207000
CY2022Q1 akya Accrued Inventory Purchases
AccruedInventoryPurchases
1868000
CY2021Q4 akya Accrued Inventory Purchases
AccruedInventoryPurchases
1877000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3905000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12138000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13491000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
389000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
413000
CY2022Q1 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
465000
CY2021Q4 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
384000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
32576000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
32471000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.54
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8082000
CY2021Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1190000
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37502358
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37424101
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8502166
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6709218
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16399000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9568000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37464496
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2706133
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-16399000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6592555
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31672608
CY2022Q1 akya Entity Number Of Business Activities
EntityNumberOfBusinessActivities
1
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16894000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12212000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
139000
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
710000
CY2022Q1 us-gaap Lease Cost
LeaseCost
855000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2212000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2739000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2286000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2255000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2107000
CY2022Q1 akya Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
682000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12281000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1970000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10311000
CY2022Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
328000
CY2022Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
356000
CY2022Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
228000
CY2022Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
23000
CY2022Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
935000
CY2022Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
103000
CY2022Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
832000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2022Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2022Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0497
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
637000
CY2022Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
6000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
126000

Files In Submission

Name View Source Status
0001558370-22-007462-index-headers.html Edgar Link pending
0001558370-22-007462-index.html Edgar Link pending
0001558370-22-007462.txt Edgar Link pending
0001558370-22-007462-xbrl.zip Edgar Link pending
akya-20220331.xsd Edgar Link pending
akya-20220331x10q.htm Edgar Link pending
akya-20220331x10q_htm.xml Edgar Link completed
akya-20220331xex31d1.htm Edgar Link pending
akya-20220331xex31d2.htm Edgar Link pending
akya-20220331xex32d1.htm Edgar Link pending
akya-20220331xex32d2.htm Edgar Link pending
akya-20220331_cal.xml Edgar Link unprocessable
akya-20220331_def.xml Edgar Link unprocessable
akya-20220331_lab.xml Edgar Link unprocessable
akya-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending